PAPER Filipovych R, Gaonkar B, Davatzikos C
SEARCH RESULTS
331395 RESULTS
PAPER Blass B
Compounds and Their Use as BACE Inhibitors: Patent Highlight.
ACS Med Chem Lett. 2012 Nov 8;3(11):875-6. Epub 2012 Oct 29 PubMed: 24900397PAPER Zeng F, Alagille D, Tamagnan GD, Ciliax BJ, Levey AI, Goodman MM
Synthesis and In Vitro Evaluation of Imidazo[1,2-b]pyridazines as Ligands for β-Amyloid Plaques.
ACS Med Chem Lett. 2010 May 13;1(2):80-4. Epub 2010 Mar 11 PubMed: 24900181PAPER Santabárbara J, Lopez-Anton R, Marcos G, De-la-Cámara C, Lobo E, Saz P, Gracia-García P, Ventura T, Campayo A, Rodríguez-Mañas L, Olaya B, Haro JM, Salvador-Carulla L, Sartorius N, Lobo A
Degree of cognitive impairment and mortality: a 17-year follow-up in a community study.
Epidemiol Psychiatr Sci. 2014 Jun 6;:1-9. PubMed: 24905936PAPER Liu NK, Zhang YP, Zou J, Verhovshek T, Chen C, Lu QB, Walker CL, Shields CB, Xu XM
A semicircular controlled cortical impact produces long-term motor and cognitive dysfunction that correlates well with damage to both the sensorimotor cortex and hippocampus.
Brain Res. 2014 Aug 12;1576:18-26. Epub 2014 Jun 4 PubMed: 24905625PAPER Fowler NR, Harrawood A, Frame A, Perkins AJ, Gao S, Callahan CM, Sachs GA, French DD, Boustani MA
The Indiana University Cognitive Health Outcomes Investigation of the Comparative Effectiveness of dementia screening (CHOICE) study: study protocol for a randomized controlled trial.
Trials. 2014 Jun 6;15:209. PubMed: 24903469Grace Hansford
PAPER Huang HJ, Lee CC, Chen CY
In silico design of BACE1 inhibitor for Alzheimer's disease by traditional Chinese medicine.
Biomed Res Int. 2014;2014:741703. Epub 2014 May 8 PubMed: 24900984PAPER Viklund J, Kolmodin K, Nordvall G, Swahn BM, Svensson M, Gravenfors Y, Rahm F
Creation of Novel Cores for β-Secretase (BACE-1) Inhibitors: A Multiparameter Lead Generation Strategy.
ACS Med Chem Lett. 2014 Apr 10;5(4):440-5. Epub 2014 Feb 3 PubMed: 24900855PAPER Rotella DP
Gamma secretase modulators.
ACS Med Chem Lett. 2013 Sep 12;4(9):823. Epub 2013 Aug 9 PubMed: 24900755PAPER Abdel-Magid AF
β-Secretase Inhibitors for the Treatment of Alzheimer's Disease and Down's Syndrome.
ACS Med Chem Lett. 2013 Jul 11;4(7):578-9. Epub 2013 May 17 PubMed: 24900714PAPER Cheng F, Cappai R, Lidfeldt J, Belting M, Fransson LÅ, Mani K
Amyloid precursor protein (APP)/APP-like protein 2 (APLP2) expression is required to initiate endosome-nucleus-autophagosome trafficking of glypican-1-derived heparan sulfate.
J Biol Chem. 2014 Jul 25;289(30):20871-8. PubMed: 24898256PAPER Xie A, Gao J, Xu L, Meng D
Shared mechanisms of neurodegeneration in Alzheimer's disease and Parkinson's disease.
Biomed Res Int. 2014;2014:648740. Epub 2014 May 12 PubMed: 24900975PAPER Kelly LP, Carvey PM, Keshavarzian A, Shannon KM, Shaikh M, Bakay RA, Kordower JH
Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson's disease.
Mov Disord. 2014 Jul;29(8):999-1009. Epub 2013 Nov 4 PubMed: 24898698PAPER Aulić S, Le TT, Moda F, Abounit S, Corvaglia S, Casalis L, Gustincich S, Zurzolo C, Tagliavini F, Legname G
Defined α-synuclein prion-like molecular assemblies spreading in cell culture.
BMC Neurosci. 2014 Jun 4;15:69. PubMed: 24898419Current Filters
No filters selected